China's Mindray diversifies into ortho space with Dragonbio
This article was originally published in Clinica
Mindray Medical has ventured into the orthopaedics space by acquiring a controlling stake in fellow Chinese company Dragonbio Surgical Implant. The move further consolidates Mindray's already dominant position in China's medical device market, and underlines its strategy to diversify into new product sectors.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.